News Room
News Room
News Room
Paragon Biosciences Launches Qlarity Imaging to Advance the First FDA-Cleared Artificial Intelligence Breast Cancer Diagnosis System
The announcement signals accelerated access to more accurate diagnosis for breast cancer patients, stemming from three decades of research at the University of Chicago. Chicago, [...]
Jeff Aronin Receives Northern Illinois University’s 2019 Innovation and Entrepreneurship Award
Jeff Aronin receives Northern Illinois University’s 2019 Innovation and Entrepreneurship Award, presented by Dr. Lisa Freeman, President of NIU, and Dr. Balaji Rajagopalan, Dean of [...]
Paragon Biosciences Names James Robinson President and Chief Operating Officer
The newly-created position is the result of rapid expansion at Paragon and its portfolio companies, which are developing novel medical treatments Chicago, IL, April 22, [...]
Jeff Aronin is Named Innovator of the Year by Best in Biz
With its highest honor, a Gold level award, Best in Biz recognizes Jeff Aronin for his lifelong commitment to developing breakthrough therapies for severe [...]
Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma
Paragon organizes new investment from Fidelity Management & Research Company and Valor Equity Partners for portfolio company Castle Creek Pharma CHICAGO, IL – October [...]
Crain’s Chicago Business: “Chicago-based Biotech Incubator Raises $71.8 Million”
October 19, 2019 – Paragon Biosciences CEO Jeff Aronin spoke with Crain’s Chicago Business on his role in the company, his vision for Paragon, and his [...]
